Music conductor with Parkinson’s sees symptoms improve with deep brain stimulation – Democratic Accent

Music conductor with Parkinson’s sees symptoms improve with deep brain stimulation

An Ohio music conductor is using deep brain stimulation to combat his Parkinson’s disease. Rand Laycock, 70, the director and conductor of a symphony orchestra, was diagnosed just before his 60th birthday, according to a press release from Cleveland Clinic. “My doctor at the time told me [a Parkinson’s diagnosis] wasn’t a death sentence, and there would be advancements over the next few years to help with my treatment,” said Laycock. STEM-CELL T…

Music conductor with Parkinson’s sees symptoms improve with deep brain stimulation – Democratic Accent

An Ohio music conductor is using deep brain stimulation to combat his Parkinson’s disease. Rand Laycock, 70, the director and conductor of a symphony orchestra, was diagnosed just before his 60th birthday, according to a press release from Cleveland Clinic. “My doctor at the time told me [a Parkinson’s diagnosis] wasn’t a death sentence, and there would be advancements over the next few years to help with my treatment,” said Laycock. STEM-CELL T…

A groundbreaking discovery of a common master switch to cure Alzheimer’s, Parkinson’s, and other brain-related diseases - Journal of Cyber Policy

Davis Joseph during the plenary presentation about his second groundbreaking discovery of a common master switch to cure Alzheimer’s, Parkinson’s, and other brain-related diseases at the International Congress of Sustainable Innovations in Medicine 2025 Davis Joseph’s Unified Theory of Alzheimer’s, Parkinson’s and other brain-related diseases Davis Joseph giving an Interview at the Paraguay-China Chamber of Commerce and Industry in Asunción, Par…

Study findings 'lay foundation' for targeted therapies in Parkinson's

A small molecule called NK036 — which inhibits USP30, an enzyme that counters the removal of damaged mitochondria from nerve cells in Parkinson’s disease — fits tightly into its target, suggesting it may have a strong and lasting effect as a treatment for the neurological condition, a new study found. Developed in the lab of Malte Gersch, PhD, at the Max Planck Institute for Molecular Physiology in Germany, NK036 sits deeply in the enzyme, formi…